Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector’s diagnostics and research industry, offers investors a compelling opportunity with a potential upside of 36.50%, according to analyst..
Investors on the hunt for opportunities in the ever-evolving biotechnology sector may find Abivax SA (ABVX) an intriguing prospect. This French biotech company, with a market capitalization of $9.16 billion,..
Sonida Senior Living, Inc. (SNDA), a key player in the medical care facilities industry, continues to draw attention for its robust revenue growth amidst a challenging market landscape. With a..
AxoGen, Inc. (NASDAQ: AXGN), a leader in the medical devices industry focused on peripheral nerve regeneration and repair, presents an intriguing opportunity for investors with its significant growth potential. Based..
Humacyte, Inc. (NASDAQ: HUMA), a biotechnology company based in Durham, North Carolina, is making waves in the healthcare sector with its groundbreaking approach to developing implantable bioengineered human tissues. Despite..
For investors looking to capitalize on the burgeoning biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity. This clinical-stage gene therapy company, with a market capitalization of approximately..
Autolus Therapeutics plc (NASDAQ: AUTL) is making waves in the biotechnology sector with its ambitious pipeline of T cell therapies aimed at treating cancer and autoimmune diseases. Based in London,..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the specialty and generic drug manufacturing sector, has recently garnered attention in the investment community for its robust potential upside. With an..
Sana Biotechnology, Inc. (NASDAQ: SANA), a healthcare sector player specializing in biotechnology, has been garnering attention in the investment community. Headquartered in Seattle, Washington, the company is making strides in..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotech sector, has captured investor attention with its ambitious approach to therapeutic innovation. Headquartered in Watertown, Massachusetts, this biotechnology company..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical device industry, has been capturing investor attention due to its promising potential upside of 58.33%. As a company operating..
As the biopharmaceutical landscape continues to evolve, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers investors a compelling opportunity to engage with the future of brain health treatments. Headquartered in New..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is a company that demands the attention of savvy investors. With a market capitalization of..
Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings. This clinical-stage biotechnology company,..
Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central nervous system (CNS) disorders...
Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, is making waves with its cutting-edge drug discovery and development software. Renowned for its use of artificial intelligence..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. Specializing in the development of monoclonal antibody therapeutics for psoriasis and..
Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and challenge within the medical devices sector. With a focus on performance coating technologies for intravascular devices and chemical components..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of medical instruments and supplies, particularly for treating peripheral vascular diseases and oncology...
LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving a niche in the rapidly expanding telehealth industry. With a market capitalization of $181.47 million, this New..
